CMPX logo

Compass Therapeutics (CMPX) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

05 April 2021

Indexes:

Not included

Description:

CMPX, or Compass Therapeutics, is a biotechnology company focused on developing innovative therapies for cancer and autoimmune diseases. They utilize advanced technologies to create monoclonal antibodies that target specific proteins, aiming to improve patient outcomes and advance treatment options in the medical field.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

15 Nov '24 HC Wainwright & Co.
Buy
12 Nov '24 HC Wainwright & Co.
Buy
11 Nov '24 HC Wainwright & Co.
Buy
16 Sept '24 Ladenburg Thalmann
Buy
12 Aug '24 HC Wainwright & Co.
Buy
07 Aug '24 Wedbush
Outperform
06 Aug '24 HC Wainwright & Co.
Buy
03 June '24 HC Wainwright & Co.
Buy
16 May '24 HC Wainwright & Co.
Buy
14 May '24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)
Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)
Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)
CMPX
zacks.com21 November 2024

Compass Therapeutics, Inc. (CMPX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock
What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock
What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock
CMPX
zacks.com15 November 2024

Compass Therapeutics, Inc. (CMPX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 Penny Stocks With the Power to 10X Your $1K Investment
3 Penny Stocks With the Power to 10X Your $1K Investment
3 Penny Stocks With the Power to 10X Your $1K Investment
CMPX
InvestorPlace24 March 2024

Today we will be looking at three penny stocks with the power to 10x your $1K investment. The three firms discussed below have outsized potential to turn a small capital allocation into a much larger return.

Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should Know
Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should Know
Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should Know
CMPX
Zacks Investment Research08 February 2024

Compass Therapeutics, Inc. (CMPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
CMPX
Zacks Investment Research14 November 2023

The heavy selling pressure might have exhausted for Compass Therapeutics, Inc. (CMPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

FAQ

  • What is the primary business of Compass Therapeutics?
  • What is the ticker symbol for Compass Therapeutics?
  • Does Compass Therapeutics pay dividends?
  • What sector is Compass Therapeutics in?
  • What industry is Compass Therapeutics in?
  • What country is Compass Therapeutics based in?
  • When did Compass Therapeutics go public?
  • Is Compass Therapeutics in the S&P 500?
  • Is Compass Therapeutics in the NASDAQ 100?
  • Is Compass Therapeutics in the Dow Jones?
  • When was Compass Therapeutics's last earnings report?
  • When does Compass Therapeutics report earnings?
  • Should I buy Compass Therapeutics stock now?

What is the primary business of Compass Therapeutics?

CMPX, or Compass Therapeutics, is a biotechnology company focused on developing innovative therapies for cancer and autoimmune diseases. They utilize advanced technologies to create monoclonal antibodies that target specific proteins, aiming to improve patient outcomes and advance treatment options in the medical field.

What is the ticker symbol for Compass Therapeutics?

The ticker symbol for Compass Therapeutics is NASDAQ:CMPX

Does Compass Therapeutics pay dividends?

No, Compass Therapeutics does not pay dividends

What sector is Compass Therapeutics in?

Compass Therapeutics is in the Healthcare sector

What industry is Compass Therapeutics in?

Compass Therapeutics is in the Biotechnology industry

What country is Compass Therapeutics based in?

Compass Therapeutics is headquartered in United States

When did Compass Therapeutics go public?

Compass Therapeutics's initial public offering (IPO) was on 05 April 2021

Is Compass Therapeutics in the S&P 500?

No, Compass Therapeutics is not included in the S&P 500 index

Is Compass Therapeutics in the NASDAQ 100?

No, Compass Therapeutics is not included in the NASDAQ 100 index

Is Compass Therapeutics in the Dow Jones?

No, Compass Therapeutics is not included in the Dow Jones index

When was Compass Therapeutics's last earnings report?

Compass Therapeutics's most recent earnings report was on 12 November 2024

When does Compass Therapeutics report earnings?

The next expected earnings date for Compass Therapeutics is 21 March 2025

Should I buy Compass Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions